Advanced Enzyme Technologies Valuation
Is ADVENZYMES undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of ADVENZYMES when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: ADVENZYMES (₹389.2) is trading above our estimate of fair value (₹374.49)
Significantly Below Fair Value: ADVENZYMES is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for ADVENZYMES?
Key metric: As ADVENZYMES is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is ADVENZYMES's PE Ratio? | |
|---|---|
| PE Ratio | 31.8x |
| Earnings | ₹1.37b |
| Market Cap | ₹43.54b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 6.4x |
| Enterprise Value/EBITDA | 20.4x |
| PEG Ratio | 1.2x |
Price to Earnings Ratio vs Peers
How does ADVENZYMES's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 91x | ||
SHK S H Kelkar | 178.4x | 44.4% | ₹39.2b |
ROSSARI Rossari Biotech | 33.2x | 22.3% | ₹46.1b |
539837 Raghav Productivity Enhancers | 123.4x | n/a | ₹38.2b |
505710 Grauer & Weil (India) | 29.2x | n/a | ₹46.8b |
ADVENZYMES Advanced Enzyme Technologies | 31.8x | 26.7% | ₹43.5b |
Price-To-Earnings vs Peers: ADVENZYMES is good value based on its Price-To-Earnings Ratio (31.8x) compared to the peer average (91x).
Price to Earnings Ratio vs Industry
How does ADVENZYMES's PE Ratio compare vs other companies in the IN Chemicals Industry?
| 4 Companies | Price / Earnings | Estimated Growth | Market Cap |
|---|---|---|---|
NAGAFERT Nagarjuna Fertilizers and Chemicals | 0.3x | n/a | US$68.08m |
526773 Pressure Sensitive Systems (India) | 0.6x | n/a | US$7.59m |
526143 MPL Plastics | 1.8x | n/a | US$1.96m |
509910 Southern Gas | 0.04x | n/a | US$6.16k |
| 4 Companies | Estimated Growth | Market Cap |
|---|
Price-To-Earnings vs Industry: ADVENZYMES is good value based on its Price-To-Earnings Ratio (31.8x) compared to the Indian Chemicals industry average (31.9x).
Price to Earnings Ratio vs Fair Ratio
What is ADVENZYMES's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 31.8x |
| Fair PE Ratio | 32x |
Price-To-Earnings vs Fair Ratio: ADVENZYMES is good value based on its Price-To-Earnings Ratio (31.8x) compared to the estimated Fair Price-To-Earnings Ratio (32x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
MOIL
₹64.6b
Engages in the exploration, development, and marketing of various grades of manganese ores in India.
533286
₹317.50
7D
9.5%
1Y
8.2%
Jindal Stainless
₹565.0b
Manufactures and sells stainless-steel flat products in India and internationally.
532508
₹685.75
7D
-0.1%
1Y
33.5%
Jindal Steel & Power
₹907.4b
Operates in the steel, mining, and infrastructure sectors in India and internationally.
JINDALSTEL
₹889.55
7D
2.8%
1Y
33.1%